2026-526859-54-00CompletedPhase 1
A Randomised, Placebo‑Controlled Trial to Assess Effect of IMU‑838 on QT/QTc
Source: EU CTIS (euclinicaltrials.eu) · Last updated 31 Jul 2026
- Status (registry)
- Completed
- Phase (registry)
- Phase 1
- Study type
- Interventional
- Enrollment
- 20 (actual)
- First submitted
- 22 Jun 2026
- Start date
- 5 Aug 2026
- Lead sponsor
- Immunic AG
- Diseases
- Multiple sclerosis
- EU CT number
- 2026-526859-54-00
What you commit to
- Study type: Interventional · Phase 1
- Participants enrolled: 20
- 1 site in 1 country
- Visits and tests: ask the trial team, the registry does not list them
Built from the registry fields of EU CTIS (euclinicaltrials.eu). It describes the study design.
Sites (1)
Sites in registry order. Save your city in your profile to sort them by distance.
| Site | City | Country | Site status |
|---|---|---|---|
| SGS Belgium | Edegem | Belgium | Completed |
This page is information, not medical advice. Discuss any trial with your doctor.